SEC Filing Analysis: Atai Beckley N.V. (ATAI)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director received a routine, non-cash stock option grant as part of their compensation package.
• Market Impact: Minimal, as this is a standard compensatory grant with a negligible potential dilution effect.

Company Information

Field	Value
Company	Atai Beckley N.V.
Ticker Symbol	ATAI
CIK	0001840904
Industry	Pharmaceutical Preparations

Insider Information

Field	Value
Name	Braunstein Scott
CIK	0001643875
Title/Position	Not Specified
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-11-04
Transaction Code	A (Grant)
Security Type	Stock Option
Shares Involved	56,818
Price Per Share	$0.00
Total Value	$0
Shares Owned After	56,818 (derivative securities)
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.0%
Shares Transacted	56,818
% of Shares Outstanding	0.027%
Post-Transaction Ownership	56,818 derivative shares
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction value is $0, making it insignificant against the company's $1.41 billion market capitalization.
• Ownership Concentration: This grant establishes a new derivative position for the insider. It does not reflect a change in common stock ownership.
• Dilution Impact: The potential dilution from these options, if exercised, is 0.027% of shares outstanding. This is a minimal and routine level of dilution for executive compensation.
• Transaction Significance: The transaction is a standard compensatory grant, not an open-market purchase, and its size is immaterial relative to the company's public float and market value.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Stock option grants are a common form of compensation and do not typically signal new information to the market or reflect insider sentiment in the same way as open-market trades.

Volume & Sentiment

• Expected Volume Impact: None. This is a non-market transaction and will not directly affect trading volume.
• Sentiment Indicator: Neutral. The market generally views such grants as a routine cost of business.

Additional Context

Transaction Notes

• Vesting Schedule: The filing's footnote specifies that 100% of the options will vest on the first anniversary of the grant date, November 4, 2026. They are not immediately exercisable.
• Expiration: The options expire on November 4, 2035.